SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David Bogdanoff who wrote (529)8/19/1997 7:01:00 PM
From: Peter E. Thorpe   of 2173
 
Hello to the thread ...

I don't know a thing about biotech, but I was impressed by the CEO
on cnbc today - even enough to speculate on some shares, so be it at
greatly reduced prices from the previous week.

imho the market overeacts to bad news. I have done well in the past
as a bottom feeder following bad news. Many times after bad news management hides from the press - I think Haugen (sp?) countered the
bad news quite well.

Of course AMLN is a one-trick pony, but I did say I took a speculative
position. Luckily, I don't know much about diabetes, but I do know that treatment is a lifelong process so even a small % of patients could result in good sales.

I have enjoyed reading the postings to this thread, and thank all for
giving me an education about AMLN.

Pete
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext